Search Results

foundational lesson from Terry Kenakin’s Pharmacology Vault , we unlock the visual language of pharmacology: dose-response In classic Terry style, the lecture walks you through: What dose-response curves are and why they’re 👉 Discover why dose-response curves are the backbone of all pharmacology. Unlock "Dose-Response Curves" now

used here to determine the different interactions of these two ligands with MOR: morphine adjusted its pose

activity becomes so dominated by experiments, data nuance, and scientific discourse that the organization loses

But as Dr. In the full lecture, Dr. Dr. Kenakin uses a lever analogy where: Efficacy is the weight applied. Dr. Why Terry’s Corner Terry’s Pharmacology Corner delivers weekly lectures from Dr.

This week in Terry’s Corner, Dr. Why Misreading Antagonism Delays GPCR Drug Discovery If a dose-response curve shifts to the right, you DR curves shift to the right with no loss of maximal effect. Each subscription includes: Weekly deep dives from Dr. Consider this: Two dose-response curves, side by side.

October 2022 Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages "The fungal pathogen Histoplasma capsulatum (Hc) invades, replicates within, and destroys and release of small peptide fragments such as C3a, a role for C3aR in macrophage interactions with fungi phagocytosis of bacteria and latex beads, it is critical for optimal macrophage capture of pathogenic fungi Hc-macrophage interactions and uncover a novel and specific role for C3aR in macrophage recognition of fungi

.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Jan Steyaert will be presented with the Gabbay Award at Brandeis University on October 27 when he will

March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced today the dosing

That choice determines whether you risk over- or under-dosing, miss safety windows, or miss therapeutic Dr. Recognizing how your ligand interacts with the receptor lets you predict safety margins, dose–response stay ahead of the science 🧠 Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin     💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr.

When PK is misunderstood early, Dr. derail programs Every therapeutic area—CNS, cardiovascular, GI—faces the same core PK constraints Dr How frequently must it be dosed to maintain effective exposure? Across therapeutic classes, Dr. small molecules, but protein binding, transporters, and tissue architecture  play decisive roles Dr Why Terry’s Corner Terry’s Corner  delivers weekly pharmacology lectures from Dr.

Featuring logos from Dr. GPCR and Revvity. Dr. The fun is what you do with the other 10%. 🎯 From Launch to Legacy For Dr. Want to hear Dr. Trinquet tell the story in his own words? GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

Dr. Frame your strategy, then let the serendipity occur.” — Dr. Want to hear Dr. Trinquet tell the story in his own words? Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

Dr. Dr. Dr. Dr. Dr.

March 2022 Confo Therapeutics Doses First Subjects In Phase 1 Clinical Trial Of CFTX-1554 For The Treatment medicines targeting G-protein coupled receptors (GPCRs), today announced that the first subjects have been dosed

For Dr. Solubility poses significant challenges. You’re just changing how bright it is—and how long it glows,” said Dr. Eric Trinquet. Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

This week’s Dr. Emerging Voices in GPCR Biology; Domain Therapeutics patents new PAR2 antagonists. 🔍 This Week in Dr 🎥  Live AMA with Dr. Kenakin — October 30, 12 PM EST   Join Dr. say in the topics covered next Weekly updates that keep your knowledge sharp Monthly live AMAs with Dr Listen to the episode ➤ Why Dr.

March 2022 ERNEST has established an Emergency Fund for Ukrainian researchers.

Dr. Dr. Dr. Dr. Dr.

Dr. As Dr. As Dr. Dr. Dr.

In this week’s lesson, Dr. Access this week’s key insight ➤ Dr. Dr. 👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr. See you in the Ecosystem, Dr. GPCR Team

However, blind assessments of ligand pose quality and affinity prediction have thus far not provided Median ligand RMSD values for top-scored poses were 1.2 Å and 2.0 Å for self-docking and StateMatch/FunctionMatch

Funding models rewarded independence, not shared resources. The Power of GPCR Collaboration: Funding as a Force Multiplier Collaboration sounds warm and fuzzy. Shared funding gave us leverage. This changed not just what got funded, but what was possible . competitive advantage. 🎧 Listen to the full episode:   Leadership, Luck, and GPCR Signaling 🔓 Join   Dr

In the full lecture, Dr. Linearity  of the Schild regression (log(DR–1) vs. antagonist concentration). As Dr. Derive dose ratios  from those sections only. Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr.

Dosing regimens aligned with biology, not just exposure. 🎥 Next Week's Release: The First AMA Session The first Ask-Me-Anything with Dr. course topics Weekly new releases  — always fresh, always relevant Live monthly AMA  sessions with Dr , pharma, and academia 💎 $2999/year — one conference cost = a full year of expert training Premium Dr Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.

In the lesson, Dr. Dr. Dr. Dr. Dr.

Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. Become a Dr. GPCR Ambassador - Share & refer with Dr. GPCR.   Join the Affiliate Program     Your Shortcut to Dr. The Dr. Best wishes, The Dr. GPCR Team

In Episode 168 of the Dr. GPCR Podcast, Dr. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful. ” — Dr. That’s the mission. ” — Dr. Maria Majellaro Now, as official partners of the Dr. Keyword Cloud:   GPCR data platform , fluorescent ligands , assay development , GPCR research community , Dr

Dr. Maria Majellaro’s story, shared in Episode 168 of the Dr. ” — Dr. Maria Majellaro Maria didn’t always know she’d end up in a startup. ” — Dr. With the new  Dr. . 👉 Explore Celtarys’ tools and partnership with Dr.

Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. Ben Clements, a tour of our official Dr. Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. The official Dr. GPCR Store is live! Best wishes, The Dr. GPCR Team

, we’re spotlighting Celtarys Research, our newest partner, featured in a blog and podcast with CSO Dr After 40+ years and 250 publications, Dr. Dr. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Stay curious, The Dr. GPCR Team